Evidence map›Paper›PMID 29543059›Full record

ArticleAnnals of the Royal College of Surgeons of England2018

Rising incidence of thyroid cancer in Singapore not solely due to micropapillary subtype.

J H Shulin, J Aizhen, S M Kuo, W B Tan, K Y Ngiam, R Parameswaran

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Annals of the Royal College of Surgeons of England, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06923826 (Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06923826 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) - A Phase 2 Multi-centre Trial

TypeinterventionalSponsorNational University Hospital, SingaporeRan2025 to 2030Enrolled32ConditionsSalivary Gland Cancer, Thyroid CancerArmsSacituzumab govitecan
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Role of TruncatedCancers · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J H ShulinDivision of Endocrine Surgery, National University Hospital , Singapore.
J AizhenNational Registry of Disease Office, Health Promotion Board , Singapore.
S M KuoNational Registry of Disease Office, Health Promotion Board , Singapore.
W B TanDivision of Endocrine Surgery, National University Hospital , Singapore.
K Y NgiamDivision of Endocrine Surgery, National University Hospital , Singapore.
R ParameswaranDivision of Endocrine Surgery, National University Hospital , Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction The annual incidence of thyroid cancer is known to vary with geographic area, age and gender. The increasing incidence of thyroid cancer has been attributed to increase in detection of micropapillary subtype, among other factors. The aim of the study was to investigate time trends in the incidence of thyroid cancer in Singapore, an iodine-sufficient area. Materials and methods Data retrieved from the Singapore National Cancer Registry on all thyroid cancers that were diagnosed from 1974 to 2013 were reviewed. We studied the time trends of thyroid cancer based on gender, race, pathology and treatment modalities where available. Results The age-standardised incidence rate of thyroid cancer increased to 5.6/100,000 in 2013 from 2.5/100,000 in 1974. Thyroid cancer appeared to be more common in women, with a higher incidence in Chinese and Malays compared with Indians. Papillary carcinoma is the most common subtype. The percentage of papillary microcarcinoma has remained relatively stable at around 38% of all papillary cancers between 2007 and 2013. Although the incidence of thyroid cancer has increased since 1974, the mortality rate has remained stable. Conclusion This trend of increase in incidence of thyroid cancer in Singapore compares with other published series; however, the rise seen was not solely due to micropapillary type. Thyroid cancer was also more common in Chinese and Malays compared with Indians for reasons that needs to be studied further.

Indexed as

Carcinoma, PapillaryFemaleHumansIncidenceMaleMiddle AgedRegistriesRetrospective StudiesSex FactorsSingaporeThyroid NeoplasmsCancerEpidemiologyThyroid

Identifiers

PMID29543059
PMCPMC5958851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.